In vitro models using breast cancer cell lines such as MDA-MB-231 and MCF-7, as well as transcriptomic data analyses from patient samples, revealed that pharmacological or genetic inhibition of Panx1 reverses the EMT phenotype and reduces cellular invasiveness. The gene discussed is PANX1; the disease is breast cancer.